Neurocrine Bioscience buy Citigroup Inc.
Start price
06.05.26
/
50%
€123.15
Target price
06.05.27
€209.89
Performance (%)
6.98%
Price
09:30
€131.75
Summary
This prediction is currently active. With a performance of 6.98%, the BUY prediction by Citigroup_Inc_ for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 06.05.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -6.615% | -6.615% |
| iShares Core DAX® | 0,44 % | 5,90 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Citigroup Inc. from $242.00 to $246.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€143.95
31.07.26
31.07.26
€216.33
31.07.27
31.07.27
-8.89%
09:30
09:30
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.90
07.04.26
07.04.26
€209.89
07.04.27
07.04.27
15.19%
09:30
09:30
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€103.35
12.02.26
12.02.26
€171.73
12.02.27
12.02.27
25.83%
09:30
09:30
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.75
29.10.25
29.10.25
€174.28
29.10.26
29.10.26
10.45%
09:30
09:30